Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta

Archives of Osteoporosis

Volumn 6, Issue 1-2, 2011, Pages 31-38

  Wekre, Lena Lande ^a   Eriksen, Erik F ^b   Falch, Jan A ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Adult; Bone marker; Bone mineral density; Osteogenesis imperfecta; Osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM ION; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; DEOXYPYRIDINOLINE; GLUCOSE; OSTEOCALCIN; PARATHYROID HORMONE; THYROTROPIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CALCIUM METABOLISM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; GENDER; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CALCIUM; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; NORWAY; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PREVALENCE;

EID: 84856109673     PISSN: 18623522     EISSN: 18623514     Source Type: Journal    
DOI: 10.1007/s11657-011-0054-z     Document Type: Article

References (32)

1. Rowe WD, Shapiro RY (1990) Osteogenesis imperfecta. In: Avioli L, Krane S (eds) Metabolic bone disease and clinical related disorders, 2nd edn. WB Saunders, USA, Philadelphia, pp 659-701
2. Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 15:101-116 (Pubitemid 9164903)
3. Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P et al (2009) Type Vosteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 15:1650-1658
4. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30-38 (Pubitemid 33150994)
5. Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, Roughley PJ, Glorieux FH (2002) Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 31:12-18 (Pubitemid 34754419)
6. Roughly PJ, Rauch F, Glorieux FH (2003) Osteogenesis imperfecta- clinical and molecular diversity. Eur Cell Mater 5:41-47 (Pubitemid 38957400)
7. Viguet-Carrin S, Garnero P, Demas PD (2006) The role of collagen in bone strength. Osteoporos Int 17:319-36
8. Paterson C, McAllon S, Stellman JL (1984) Osteogenesis imperfecta after the menopause. N Eng J M 310:1694-1696 (Pubitemid 14124590)
9. Primorac D, Rowe DW, Mottes M, Barišić I, Antičević D et al (2001) Osteogenesis imperfecta at the beginning of bone and joint decade. CMJ 42:393-415 (Pubitemid 32781446)
10. Adami S, Gatti D, Colapietro F, Fracassi E, Braga V, Rossini M, Tato L (2003) Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res 18:126-130 (Pubitemid 36008347)
11. Whyte MP (1999) Osteogenesis imperfecta. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th edn. Lippincott-Williams andWilkins, Philadelphia, pp 386-389
12. Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH (2003) Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab 88:986-992 (Pubitemid 36337744)
13. Meunier PJ (1999) Serum 25-hydroxy-vitamin D is often low, indicating vitamin D deficiency secondary to lack of exposure to sunlight, Abstractbook, 7th International Conference onOsteogenesis Imperfecta, Montreal, 1999
14. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers C (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Eng J Med 339:947-952 (Pubitemid 28455096)
15. Astrom E, Söderhall S (2002) Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 86:356-364 (Pubitemid 34478233)
16. Rauch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 110:1293-1299 (Pubitemid 35285755)
17. Gatti D, Colapietro F, Fracassi E, Sartori E, Antoniazzi F, Braga V, Rossini M, Adami S (2003) The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. J Clin Densitom 6:173-177 (Pubitemid 36693812)
18. Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S (2004) Bone turnover markers in patients with osteogenesis imperfecta. Bone 34:1013-1016 (Pubitemid 38749238)
19. Cepollaro C, Gonelli S, Pondrelli C, Montagnani A, Martini S, Bruni D, Gennari C (1999) Osteogenesis imperfecta: bone turnover, bone density and ultrasound parameters. Cacif Tissue Int 65:129-132 (Pubitemid 29350650)
20. Lund AM, Hansen M, Kollerup G, Juul A, Teisner B, Skovby F (1998) Collagen-derived markers of bone metabolism in osteogenesis imperfecta. Acta Paediatr 87:1131-1137 (Pubitemid 28538422)
21. Shapiro JR (1995) Comments. J Bone Miner Res 10:338-339
22. Brenner RE, Vetter U, Bollen AM, Morike M, Eyre DR (1994) Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 9:993-997 (Pubitemid 24191786)
23. Rauch F, Travers R, Parfitt AM, Glorieux FH (2000) Static and dynamic bone histometry in children with osteogenesis imperfecta. Bone 26:581-589 (Pubitemid 30301650)
24. Chines A, Petersen DJ, Schrank FW, Whyte MP (1991) Hypercalciuria in children severely affected with osteogenesis imperfecta. J Pediatr 119:51-57
25. WHO Scientific Group on the Prevention and Management of Osteoporosis (2000: Geneva, Switzerland) Prevention and management of osteoporosis: report of a WHO scientific group. (WHO Technical Report Series No 921)
26. Wekre LL, Froslie KF, Haugen L, Falch JA (2010) A populationbased study of demographical variables and ability to perform activities of daily living in adults with osteogenesis imperfecta. Disabil Rehabil 32:579-587
27. Teegarden D, Proulx WR, Martin BR, Zhao J, McCabe GP, Lyle RM, Peacock M, Slemenda C, Johnston CC, Weaver CM (1995) Peak bone mass in young women. J Bone Miner Res 10:711-715
28. Marini JC (1988) Osteogenesis imperfecta: comprehensive management. Adv Pediatr 35:391-426
29. Gjesdal CG, Aanderud SJ, Haga HJ, Brun JG, Tell GS (2004) Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values. Osteoporos Int 15:525-534. (Pubitemid 38899913)
30. Chevrel G Osteogenesis imperfecta. Orphanet encyclopedia, June 2004 Available at: http://www.orpha.net/data/patho/GB/uk-OI.pdf
31. Huang RP, Ambrose CG, Sullivan E, Haynes RJ (2006) Functional significance of bone density measurements in children with osteogenesis imperfecta. JBJS Am 88:1324-1330 (Pubitemid 43837128)
32. Paterson CR, Mole PA (1994) Bone density in osteogenesis imperfecta may well be normal. Postgrad Med J 70:104-107 (Pubitemid 24074628)